Clinical trials: When to start and when to stop

Lancet

Volumn 359, Issue 9316, 2002, Pages 1449-

  Hey, Edmund ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CISAPRIDE; ETAMSYLATE; FRESH FROZEN PLASMA; IBUPROFEN; PANCURONIUM; PHENOBARBITAL;

BRAIN HEMORRHAGE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; GASTROESOPHAGEAL REFLUX; HUMAN; MEDICAL RESEARCH; NOTE; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY HYPERTENSION;

EID: 0037181649     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)08463-5     Document Type: Note

References (14)

1. Cochrane's epitaph for cisapride in childhood gastro-oesophageal reflux
2. Prevention of periventricular-intraventricular hemorrhage
3. Outcome of children in the indomethacin intraventricular hemorrhage prevention trial
4. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants
5. Early ibuprofen administration to prevent patent ductus arteriosus in premature newborn infants
6. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant
7. Randomised double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus
8. A comparison of ibuprofen and indomethacin for closure of patent ductus
9. Ibuprofen and patent ductus arteriosus
10. The role of data monitoring committees
11. Therapy in type 2 diabetes, cardiovascular death and the UGDP
12. Prostacyclin concentrations and transitional circulation in preterm infants requiring mechanical ventilation
13. Prophylaxis of patent ductus arteriosus with ibuprofen in premature infants
14. Prophylactic ibuprofen therapy of patient ductus arteriosus in preterm infants